Topiramate Induced Acute Angle Closure Glaucoma

A Aminlari*, M East, W Wei, D Quillen
Department of Ophthalmology, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, USA

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 2068
Abstract HTML Views: 1781
PDF Downloads: 609
Total Views/Downloads: 4458
Unique Statistics:

Full-Text HTML Views: 1039
Abstract HTML Views: 1059
PDF Downloads: 420
Total Views/Downloads: 2518

Creative Commons License
2008 Bentham Science Publishers Ltd.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Pennsylvania State University, Milton S. Hershey Medical Center, Department of Ophthalmology, Hershey PA 17033, USA; E-mail:


Topiramate is an oral sulphamate medication primarily used for seizure, migraine and neuropathic pain. It has been associated with secondary angle closure, which can mimic acute angle closure glaucoma. Suspicion for medication induced angle closure glaucoma should be higher whenever angle closure presents bilaterally. We present two cases of bilateral angle closure glaucoma secondary to topiramate.